European health regulators on Friday conditionally approved Amgen Inc’s rare blood cancer drug, Blincyto, which is one of the world’s most expensive cancer treatments. The U.S. Food and Drug Administration in December approved Blincyto for acute lymphoblastic leukemia (ALL), which has few treatment options once a patient has relapsed. Blincyto is a so-called bispecific antibody, […]

Roche is expecting the European Commission this year to issue a final decision on a drug combination to treat advanced skin cancer, based on a drug panel’s positive opinion made public on Friday.   The European Union’s Committee for Medicinal Products for Human Use, or CHMP, has adopted a positive opinion for Cotellic, when used […]

Novartis AG’s new heart failure drug Entresto is on track to be approved for use in Europe by the end of the year after it received the backing of EU regulators, the company said on Friday.   Entresto, also known as LCZ696, is the first new drug in decades for helping patients whose lives are […]

STOCKHOLM – Novo Nordisk (NVO) reported today that its type 2 diabetes treatment Victoza in combination with metformin, proved superior in reducing HbA1c than Sanofi’s lixisenatide in combination with metformin.   Novo’s stock jumped slightly this morning to a price of $56.37, up from its opening $55.94 per share. In the head-to-head trial, which surveyed […]

Germany’s Merck KGaA said it would submit its cladribine tablets to treat multiple sclerosis for registration in Europe, taking aim at a comeback for a drug it had given up on four years ago. “The decision follows the company’s evaluation of new data and additional analyses of the compound’s benefit-risk profile,” the diversified healthcare and […]

Pfizer suffered a major setback in Britain on Thursday when the High Court in London ruled that claims of patent protection for the use of its $5 billion-a-year drug Lyrica as a pain treatment were invalid.   Lyrica, known generically as pregabalin, was originally developed for epilepsy. However, further research showed it could also help […]

Roche Chief Executive Severin Schwan criticized Britain’s health system on Tuesday after two of the company’s cancer drugs were dropped from use, calling it a “stupid” way to control costs that could jeopardize research in the country. He also criticized India, an emerging economic powerhouse, for not doing more to increase its spending on healthcare. […]

Novartis AG said on Friday it received European Union approval for Farydak, a treatment for multiple myeloma that the company said gives new options for adult patients whose disease has progressed following standard therapy. Novartis received similar approval for Farydak from the U.S. Food and Drug Administration in February for treating multiple myeloma, a form […]

Gilead Sciences Inc said on Wednesday its experimental fixed-dose combination treatment for HIV proved as effective in a late-stage study as the company’s widely used Truvada combo pill but with significantly less loss of bone mineral density and kidney function. The company has already sought U.S. and European marketing approval for the new combo pill […]

Amgen is launching its injectable cholesterol drug in Europe at around half the U.S. price, in a move likely to stoke controversy about the way Americans end up paying far more than others for new medicines. Repatha belongs to a potent and expensive new class of drugs for lowering “bad” LDL cholesterol, whose high cost […]